Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | REN | P00797 | 1/20 | 0.40 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.39 |
| ▸ | CTSD | P07339 | 1/20 | 0.39 |
| ▸ | OPRD1 | P41143 | 4/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.38 |
| ▸ | CMA1 | P23946 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | CALCRL | Q16602 | 2/20 | 0.37 |
| ▸ | CD4 | P01730 | 1/20 | 0.37 |
| ▸ | RAMP1 | O60894 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5367473 | 0.84 | PTPN1 (0.41) | RENNTSR1OPRD1PTPN1 | |
| SCHEMBL2946630 | 0.83 | FAP (0.40) | NTSR1ELANEOPRD1CALCRLRAMP1 | |
| SCHEMBL5367479 | 0.83 | F2 (0.42) | RENNTSR1OPRD1 | |
| SCHEMBL31558763 | 0.82 | F2 (0.46) | RENNTSR1OPRD1CMA1 | |
| SCHEMBL29814554 | 0.80 | PTPN1 (0.43) | RENNTSR1PTPN1 | |
| SCHEMBL29401177 | 0.78 | CMA1 (0.43) | RENPTPN1CMA1KMT2A | |
| SCHEMBL29706165 | 0.77 | XIAP (0.46) | ELANECMA1KMT2A | |
| SCHEMBL15006480 | 0.77 | REN (0.44) | RENNTSR1OPRD1PTPN1KMT2A | |
| SCHEMBL30143372 | 0.76 | KMT2A (0.47) | KMT2A | |
| SCHEMBL31113348 | 0.76 | PSMB9 (0.46) | OPRD1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3691779-B1 | USE OF A COPOLYMER FOR THE STABILISATION OF AN EMULSION | UNIV BORDEAUX (FR) | 2023-06-07 | — | — | EP | disclosed |
| US-20210069118-A1 | NEW POLYMERIC EMULSIFIER AND USES THEREOF FOR THE ENCAPSULATION OF HYDROPHOBIC OR HYDROPHILIC ACTIVE COMPOUNDS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2021-03-11 | — | — | US | disclosed |
| WO-2019068936-A1 | NEW POLYMERIC EMULSIFIER AND USES THEREOF FOR THE ENCAPSULATION OF HYDROPHOBIC OR HYDROPHILIC ACTIVE COMPOUNDS | UNIVERSITÉ DE BORDEAUX (FR) | 2019-04-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210069118-A1 | NEW POLYMERIC EMULSIFIER AND USES THEREOF FOR THE ENCAPSULATION OF HYDROPHOBIC OR HYDROPHILIC ACTIVE COMPOUNDS | LIPA, IDUA, IDE | REN 2008/4885NTSR1 1330/4885ELANE 194/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.